Should the Sgarbossa criteria be applied to ECG interpretation in a ventricular paced rhythm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Sgarbossa Criteria Should Be Applied to Ventricular Paced Rhythms

The Sgarbossa criteria are validated and should be used to diagnose acute myocardial infarction in patients with ventricular paced rhythms, with the modified Sgarbossa criteria (MSC) offering superior sensitivity compared to the original criteria. 1

Evidence-Based Rationale

The American College of Emergency Physicians Clinical Policy explicitly states that Sgarbossa criteria, originally developed for left bundle branch block (LBBB), have been investigated and validated for ventricular paced patterns 1. In the landmark GUSTO-I trial, Sgarbossa et al. studied 32 patients with AMI and paced rhythm, identifying three electrocardiographic findings independently predictive of AMI in paced rhythm:

  • ST-segment elevation ≥5 mm and discordant with QRS complex (sensitivity 53%, specificity 88%)
  • ST-segment elevation ≥1 mm and concordant with QRS complex (sensitivity 18%, specificity 94%)
  • ST-segment depression ≥1 mm in leads V1-V3 (sensitivity 29%, specificity 82%)

Modified Sgarbossa Criteria: The Superior Approach

The modified Sgarbossa criteria demonstrate significantly better sensitivity (81% vs 56%) while maintaining high specificity (96%) compared to the original criteria 2. The most recent high-quality research from 2021, involving 251 patients across 16 international cardiac centers, definitively established the MSC as more sensitive for detecting acute coronary occlusion in ventricular paced rhythm 2.

The key modification replaces the "≥5 mm discordant ST elevation" criterion with a proportional criterion: ST elevation/S-wave depth ratio ≥-0.25 (or ≥-0.20 for increased sensitivity) 3, 4, 2.

Practical Application Algorithm

When evaluating a paced rhythm ECG for AMI:

  1. First, verify true ventricular pacing - look for pacing spikes preceding wide QRS complexes
  2. Apply modified Sgarbossa criteria:
    • Concordant ST elevation ≥1 mm in any lead with positive QRS
    • Concordant ST depression ≥1 mm in V1-V3
    • Proportionally excessive discordant ST elevation (ST/S ratio ≥-0.25)
  3. Consider adding: Concordant ST depression in V4-V6 increases sensitivity to 86% 2

Critical Caveats

Important exception: Do NOT apply Sgarbossa criteria to left bundle branch area (LBBA) pacing, which produces narrow QRS complexes with incomplete RBBB morphology 5. In LBBA pacing, ST-segment deviations should be interpreted more conventionally, as the QRS morphology differs fundamentally from traditional right ventricular pacing.

For traditional right ventricular pacing with wide QRS complexes, the Barcelona algorithm has also shown promise as an alternative diagnostic tool 6, though the modified Sgarbossa criteria remain the most extensively validated approach.

Clinical Impact on Mortality

The presence of concordant ST-segment changes in paced rhythm is associated with significantly higher 30-day mortality compared to enzyme elevation without concordant changes 7. This underscores the critical importance of recognizing these patterns for timely reperfusion therapy.

The modified Sgarbossa criteria with a ratio of -0.25 (or -0.20 for higher sensitivity) should be your default approach 4, 2, as they provide the optimal balance of sensitivity and specificity for detecting life-threatening coronary occlusion in ventricular paced rhythm.

References

Related Questions

What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
1. What is the major health problem resulting from a pulse deficit? (A) Bradycardia (B) Activity intolerance (C) Decreased cardiac output (D) Impaired tissue perfusion. 2. What should the nurse do when a pulse deficit is suspected? (A) Measure the radial pulse for one minute, then measure the apical pulse for one minute (B) Measure the radial pulse for 30 seconds, then measure the apical pulse for 30 seconds (C) Measure the radial pulse for one minute, wait five minutes, then measure the apical pulse for one minute (D) Ask another health‑care provider to count the radial pulse while the nurse counts the apical pulse. 3. After identifying a pulse deficit, which action should the nurse perform? (A) Reassess the apical‑radial pulse in five minutes (B) Assess the patient for signs of decreased cardiac output (C) Notify the primary health‑care provider of the pulse deficit (D) Initiate interventions directed toward managing the patient’s symptoms. 4. A patient has oral temperature 36.8 °C, radial pulse 112 weak and thready, apical pulse 117 regular, respirations 24 regular, blood pressure 104/56 right arm, 102/50 left arm; what is the pulse deficit? (A) 2 (B) 5 (C) 6 (D) 48. 5. Which of the following is an early manifestation of decreased cardiac output? (A) Fatigue (B) Substernal pain (C) Nail‑bed cyanosis (D) Shortness of breath.
In a 24-year-old woman who experiences severe nausea, shakiness, and dizziness lasting about 30 minutes after sexual intercourse, what are the possible differential diagnoses?
How should a 2-year-old child presenting with a dry cough and wheezing be managed?
Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
How serious is an atrioventricular (AV) block?
What is the appropriate pediatric regimen (dose, application frequency, duration, and precautions) for clotrimazole 2% cream in a child with suspected cutaneous candidiasis?
How long do denosumab anti‑drug antibodies persist after treatment?
How should I transition from morning dosing to bedtime dosing of guanfacine?
How should cinacalcet (Sensipar) be adjusted in a patient with primary hyperparathyroidism whose vitamin D level is declining?
What is the difference between the subarachnoid space and the dural (epidural) space?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.